Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer Meeting Abstract
| Authors: | Audeh, M. W.; Penson, R. T.; Friedlander, M.; Powell, B.; Bell-McGuinn, K. M.; Scott, C.; Weitzel, J. N.; Carmichael, J.; Tutt, A. |
| Abstract Title: | Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 277s |
| Language: | English |
| ACCESSION: | WOS:000276606600002 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.5500 |
| Notes: | Meeting Abstract: 5500 -- Source: Wos |
